Parkinson’s disease a potential pathogenetic factor for coronary artery disease and stroke, study suggests

Researchers performed a two-sample Mendelian randomization (MR) analysis to explore causal associations between Parkinson’s disease (PD) and cardio-cerebrovascular diseases.

Arcus and Gilead terminate development for etrumadenant in prostate cancer – Pharmaceutical Technology

Gilead and Arcus have an agreement providing Gilead with US and global marketing rights to Arcus’ immune-oncology pipeline, except in any territories where Arcus had

August 8, 2023

A new obesity biotech; UroGen aims to raise $107M

Plus, news about Otsuka, Ionis, Ability Biologics, Santhera, Mustang Bio and Vaxart: New biotech joins obesity race: Supercede Therapeutics raised an undisclosed seed round from

June 19, 2024

OU research focuses on innovative combination of imaging techniques to detect pancreatic cancer

Researchers at OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences have embarked on a revolutionary new research study that could improve

January 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.